Latest Quarter
Q2 FY2026ended 2026-06-30 · filed 2026-07-30
$124.61M
$5.96M
$9.15M
$0.13
$22.73M
$586.78M
$272.67M
$116.38M
What this quarter tells us
For Q1 FY2026 ended March 31, 2026, Core Laboratories reported revenue of $121.8 million, down 1.4% year-over-year. Net income was a loss of $0.8 million, a significant decline from the prior year. Operating income fell 57.3% to $1.9 million, and diluted EPS was -$0.02. The company had $22.8 million in cash, $268.9 million in equity, and $117.0 million in long-term debt.
- •Revenue decreased 1.4% YoY to $121.8 million.
- •Net loss of $0.8 million vs. prior year profit.
- •Operating income down 57.3% to $1.9 million.
- •Diluted EPS of -$0.02; long-term debt of $117.0 million.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.